![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
ASSESSING THE VIROLOGIC IMPACT OF ARCHIVED RESISTANCE IN AN HIV-1 Switch Study TANGO Through Week 48
|
|
|
CROI 2020 March 8-11
Reported by Jules Levin
Ruolan Wang,1Jonathan Wright,2, Khaled,3Allan R. Tenorio,1Maria Claudia Nascimento,3Thomas Lutz,4Daniel Podzamczer,5Richard Moore,6Miguel Górgolas Hernández-Mora,7Clifford Kinder,8Jean van Wyk,3Mark Underwood1
1ViiV Healthcare, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Stockley Park, UK; 3ViiV Healthcare, Brentford, UK; 4Infektio Research GmbH & Co. KG, Frankfurt, Germany; 5Hospital Universitari de Bellvitge, Barcelona, Spain; 6Northside Clinic, Fitzroy North, VIC, Australia; 7Jiménez Díaz Foundation University Hospital, Madrid, Spain; 8The Kinder Medical Group, Miami, FL, USA
![0313201](../images/031320/031320-3/0313201.gif)
![0313202](../images/031320/031320-3/0313202.gif)
![0313203](../images/031320/031320-3/0313203.gif)
![0313204](../images/031320/031320-3/0313204.gif)
![0313205](../images/031320/031320-3/0313205.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|